Osteofos 70 Tablet 4

• Treatment and prevention of osteoporosis in postmenopausal women: Osteofos 70 mg tablet increases bone density and reduces the risk of fractures in women who have osteoporosis or are at risk of developing it after menopause.
• Treatment to increase bone mass in men with osteoporosis: Low levels of testosterone hormone, which is responsible for various male characteristics and functions, can contribute to bone loss in men. Osteofos 70 mg tablet is also effective in increasing bone mass and strength in men who have osteoporosis. 
• Treatment of glucocorticoid-induced osteoporosis: Long-term use of glucocorticoid medications can lead to decreased bone density and increased risk of fractures. Osteofos 70 can help prevent fractures and improve bone density in such cases.
• Treatment of Paget's disease of the bone in men and women: Osteofos 70 slows down the excessive bone remodelling process. It helps to manage the disease, reduce symptoms, and prevent fractures and deformities.

• Take Osteofos 70 mg in the morning, at least 30 minutes before your meal.
• Swallow the whole tablet with a glass of water.
• Do not crush or chew the tablet, as this may affect the way the medication is absorbed in the body.
• Refrain from eating, drinking or taking any other medications (including vitamins or antacids) for at least 30 minutes after consuming the tablet. 
• Do not lie down for at least 30 minutes after taking the tablet. 
• Adhere to the prescribed instructions and refrain from altering the dosage or increasing the tablet frequency.

Osteofos 70 mg tablets are administered orally.

• Alendronate or alendronic acid, the active ingredient in Osteofos 70 mg tablet, belongs to a class of medications called amino-bisphosphonates. It works by inhibiting the activity of osteoclasts. These are cells responsible for breaking down bone tissue. By reducing bone breakdown, alendronate helps increase bone density and reduce the risk of fractures in individuals with osteoporosis. 

• Store this medicine at a temperature below 30 ºC.
• Protect it from light and moisture.
• Keep Osteofos 70 away from children.
• Do not use this medicine after the expiry date has passed.

• Patients taking a human parathyroid hormone drug for hypoparathyroidism should avoid taking this medication.
• Your calcium level may fall with the medication.
• Inform your doctor if you experience mouth sores or food pipe discomfort after taking the medication.
• Keep track of your calcium levels and bone mineral density before starting the medication and continue monitoring them for 6 to 12 months after starting the medication.
• Do not pass this medication on to others with similar symptoms. It may harm them.